← Back to Vaccine Database

rVSV-SARS-CoV-2-S Vaccine (IIBR-100)

Viral vector (replicating) vaccine · VDDBV0668

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (replicating) vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT04608305 Phase 2COVID-19
NCT04990466 Phase 3COVID-19